|
ZBTB46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89656999999288E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.356250E-04 |
| Normal-vs-Stage2 |
2.162200E-02 |
| Normal-vs-Stage3 |
4.981800E-03 |
| Normal-vs-Stage4 |
2.20759999999265E-05 |
| Stage1-vs-Stage2 |
9.256200E-01 |
| Stage1-vs-Stage3 |
3.973000E-01 |
| Stage1-vs-Stage4 |
5.524400E-02 |
| Stage2-vs-Stage3 |
6.343200E-01 |
| Stage2-vs-Stage4 |
1.204010E-01 |
| Stage3-vs-Stage4 |
3.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78869999999387E-05 |
| Normal-vs-AfricanAmerican |
8.715500E-03 |
| Normal-vs-Asian |
4.240000E-04 |
| Caucasian-vs-AfricanAmerican |
1.943400E-01 |
| Caucasian-vs-Asian |
2.870400E-01 |
| AfricanAmerican-vs-Asian |
7.936000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38989999999939E-05 |
| Normal-vs-Female |
3.430300E-04 |
| Male-vs-Female |
8.811600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.40099999999832E-05 |
| Normal-vs-Extreme_Weight |
4.12720000000366E-05 |
| Normal-vs-Obese |
3.530000E-02 |
| Normal-vs-Extreme_Obese |
2.647600E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.919000E-01 |
| Normal_Weight-vs-Obese |
3.651900E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.441200E-01 |
| Extreme_Weight-vs-Obese |
9.379600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.015000E-01 |
| Obese-vs-Extreme_Obese |
3.739500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.795400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.764900E-03 |
| Normal-vs-Age(61-80Yrs) |
4.00939999978256E-07 |
| Normal-vs-Age(81-100Yrs) |
2.93580000310101E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.068600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.264200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.439400E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.821100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.18380000000163E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.319800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.358180E-03 |
| Normal-VS-Type2 PRCC |
2.84049450627322E-11 |
| Normal-VS-KIRP CIMP |
3.914800E-01 |
| Normal-VS-Unclassified PRCC |
1.986390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.90779999762614E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.728600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.297600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.155730E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.157300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.190800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.31339999951552E-07 |
| Normal-vs-N1 |
3.014500E-04 |
| Normal-vs-N2 |
5.799000E-01 |
| N0-vs-N1 |
6.414400E-01 |
| N0-vs-N2 |
3.047400E-01 |
| N1-vs-N2 |
4.319200E-01 |
|
|
